Product Categories
| Country: | China |
|---|---|
| Tel: | 021-58521787 |
| Mobile: | 17701827760 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Argireline | C34H60N14O12S | 616204-22-9 | Details |
| Rosuvastatin methyl ester | C23H30FN3O6S | 147118-40-9 | Details |
| 4-Chloromethyl-5- meth-yl-1,3-dioxol- 2-one | C5H5ClO3 | 80841-78-7 | Details |
| Ethyl 4-(1-hydroxy-1-methyl-ethyl)-2-propyl- imidazole-5- carboxylate | C12H20N2O3 | 144689-93-0 | Details |
| Methyl 4'-bromomethyl biphenyl-2-carboxylate | C15H13BrO2 | 114772-38-2 | Details |
| 2-n-Propyl-4-methyl-6-(1-methylbenzimi- dazole-2-yl)benz- imidazole | C19H20N4 | 152628-02-9 | Details |
| Valsartan methyl ester | C25H31N5O3 | 137863-17-3 | Details |
| Silodocin P-1 oxalate | Details |
| Rabamipide Na | Details |
| Dapoxetine free base | C21H23NO | 119356-77-3 | Details |
| Tadanafil P-1 | C22H19ClN2O5 | 171489-59-1 | Details |
| Dantrolene free base | C14H10N4O5 | 85008-71-5 | Details |
| Varenicline free base | C13H13N3 | 249296-44-4 | Details |
| N-(4-cyanophenyl)- glycine | C9H8N2O2 | 42288-26-6 | Details |
| Ethyl N-[3-amino-4-(methylamino)benzoyl]-N- pyridin-2-yl-beta- alaninate | C18H22N4O3 | 212322-56-0 | Details |
| Ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1- methyl-1H-benz- imidazol-5-yl)- carbonyl]-N-pyridin- 2-yl-beta-alaninate | C27H26N6O3 | 211915-84-3 | Details |
| (S)-2,3-Dimethyl-3-(( triethylsilyl)oxy)butan-1-ol | C12H28O2Si | 957997-83-0 | Details |
| (S)-3-(methoxymetho-xy)-2,3-dimethylbutan-1-ol | C8H18O3 | 1217719-34-0 | Details |
| (R)-(2,3-dimethyl-3-(( triethylsilyl) oxy)butyl)- diphenylphosphine oxide | C24H37O2PSi | 1227926-70-6 | Details |
| (R)-(2,3-dimethyl-3- butyl)diphenyl phosphineoxide | C18H23OP | Details |
| (2S)-2-((1R,3aR,7aR)-4-((tert-butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol | C19H38O2Si | 215509-33-4 | Details |
| (1R,3aR,7aR)-1-((2R,5S,E)-6-(methoxy methoxy)-5,6-dimethylhept-3-en-2-yl)-7a- methylhexahydro- 1H-inden-4(2H)-one | C21H36O3 | 100858-26-2 | Details |
| (1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl-6- ((triethylsilyl)oxy)hept-3-en-2-yl)-7a-methyl hexahydro-1H- inden-4(2H)-one | C25H46O2Si | 950586-26-2 | Details |
| 2-((3R,5R)-3,5-bis(( tert-butyldimethyl silyl)-oxy) cyclohexylidene) ethanol | C20H42O3Si2 | 139356-37-9 | Details |
| (2-((3R,5R)-3,5-bis(( tert-butyldimethyl- silyl)oxy)cyclohexyl- idene)ethyl)diphenylphosphine oxide | C32H51O3PSi2 | 139356-39-1 | Details |
| ATB-1 | C10H13FO | 1262414-96-9 | Details |
| ATB-4 | C8H5BrClF3 | 237761-77-2 | Details |
| Diallyl bisphenol A | C21H24O2 | 1745-89-7 | Details |
| 5,6-Dihydroxyindole | C8H7NO2 | 3131-52-0 | Details |
| 5,6-Dihydroxy-1H-Indole-2-Carboxylic Acid | C9H7NO4 | 4790-08-3 | Details |
| Methyl 5,6-dihydroxy-1H-indole-2-Carboxylate | C10H9NO4 | 10131-14-3 | Details |
| 2,2-dimethyl-5H-1,3-dioxol[4,5-f]indole | C11H11NO2 | 437757-21-6 | Details |
| (E)-methyl 3-(2,2-dimethylbenzo[d][1,3]dioxol-5-yl)acrylate | C13H14O4 | 2187481-85-0 | Details |
| Cis-Sertraline-D-Madenlic acid | Details |
| Sitagliptin impurity 1~5 | C10H11ClF3NO2 | 1217809-78-3 | Details |
| Methyl caffeate | C10H10O4 | 67667-67-8 | Details |
| Quinic acid | C7H12O6 | 77-95-2 | Details |
| Phenethyl caffeate | C17H16O4 | 104594-70-9 | Details |
| ATB-9 | C12H9F6NO2 | 875444-10-3 | Details |
| Caffeic acid | C9H8O4 | 331-39-5 | Details |
| Landiolol impurity 1 | C25H40ClN3O8 | 1253907-85-5 | Details |
| Landiolol impurity 2 | C25H40ClN3O8 | 1253907-81-1 | Details |
| Landiolol impurity 3 | C25H40ClN3O8 | 1253907-83-3 | Details |
| Dabigatran amidine HCl | 211914-50-5 | Details |
| Indobufen impurity 2 | C20H21NO3 | 36691-02-8 | Details |
| Indobufen impurity 3 | C18H19NO4 | 203313-55-7 | Details |
| Sarpogrelate HCl | C24H31NO6 | 125926-17-2 | Details |
| BP984 | C20H28ClNO3 | 135261-74-4 | Details |
| Crisaborole impurity 1 | C14H11BO5 | 906673-43-6 | Details |
| Crisaborole impurity 2 | C14H12BNO4 | 1187188-59-5 | Details |
| Crisaborole impurity 3 | C14H11NO2 | 888967-63-3 | Details |
| Sitagliptin impurity 1 | C16H19F5N5O5P | 1345822-87-8 | Details |
| Sitagliptin impurity 2 | C16H19F5N5O5P | 1345822-86-7 | Details |
| Sitagliptin impurity 3 | C16H16F6N5O5P | 823817-58-9 | Details |
| Sitagliptin impurity 4 | C16H18F6N5O5P | 823817-57-8 | Details |
| Sitagliptin impurity 5 | C6H5F3N4O | 837430-15-6 | Details |
| Lesinurad sodium | C17H13BrN3O2S.Na | 1151516-14-1 | Details |
| de-bromo Lesinurad | C17H15N3O2S | 1533519-93-5 | Details |
| Benserazide HCl | C10H16ClN3O5 | 14919-77-8 | Details |
| Benserazide P-1 | C10H14ClN3O5 | 1353749-74-2 | Details |
| Silodosin P-1 oxalate | C27H32F3N3O7 | 1883697-83-3 | Details |
| Silodosin impurity 2 | C25H30F3N3O4 | 175870-21-0 | Details |
| Rebamipide sodium salt | Details |
| Rebamipide meta-Cl impurity | C19H15ClN2O4 | 90098-05-8 | Details |
| Roxatidine impurity 1 | C12H17NO | 73279-04-6 | Details |
| Roxatidine impurity 3 | C16H24N2O2 | 78274-00-7 | Details |
| Roxatidine impurity 4 | C17H27ClN2O2 | 97900-87-3 | Details |
| Elagolix impurity 1 | C32H28F5N3O4 | 2248628-93-3 | Details |
| Elagolix impurity 3 | C32H31F4N3O5 | 2375499-61-7 | Details |
| Erdosteine | C8H11NO4S2 | 84611-23-4 | Details |
| Ilaprazole | C19H18N4O2S | 172152-36-2 | Details |
| Ilaprazole intermediate P-3 | C11H9N3S | 172152-53-3 | Details |
| Ilaprazole impurity 1 | C19H18N4O3S | 172152-37-3 | Details |
| Ilaprazole impurity 3 | C9H9N3OS | 84445-90-9 | Details |
| Ilaprazole impurity 4 | C11H9N3O | 1018229-53-2 | Details |
| Fexuprazan P-4 | C13H11F2NO3 | 1902955-29-6 | Details |
| Fexuprazan P-1 | C18H12F3NO4S | 1902955-31-0 | Details |
| N-Bn Tegoprazan parent nucleus | C18H19N3O2 | 1640981-20-9 | Details |
| N-Ts Tegoprazan P-1 | 4942485-42-9 | Details |
| N-Bn Tegoprazan P-1 | Details |
| R-Tegoprazan isomer | C20H19F2N3O3 | 942195-56-4 | Details |
| Vonoprazan Fumarate | C21H20FN3O6S | 1260141-27-2 | Details |
| Deoxycholic acid P-1 | C28H46O5 | 181270-68-8 | Details |
| Deoxycholic acid impurity 1 | Details |
| Deoxycholic acid impurity 2 | C26H44O4 | 69519-35-3 | Details |
| Deoxycholic acid impurity 3 | Details |
| Sodium Picosulfate impurity A | C18H16NNaO5S | 32500-19-9 | Details |
| Diclofenac Epolamine impurity 2 | C13H9Cl2NO2 | 13625-57-5 | Details |
| Diclofenac Epolamine impurity 4 | C14H11BrClNO2 | 127792-23-8 | Details |
| Diclofenac Epolamine impurity 6 | C8H8N2 | 42088-52-8 | Details |
| Diclofenac Epolamine impurity 7 | C13H11Cl2N | 172494-87-0 | Details |
| Pranoprofen P-2 | C15H12ClNO2 | 146330-68-9 | Details |
| Pranoprofen impurity B | C15H11NO3 | 52549-22-1 | Details |
| Raloxifene HCl P-1 | C30H32ClNO4S | 84541-36-6 | Details |
| Raloxifene impurity 1 | C29H29NO4S.ClH | 84541-37-7 | Details |
| Raloxifene impurity 2 | C29H29NO4S.ClH | 173773-26-7 | Details |
| Glimepiride Cis isomer | C24H34N4O5S | 684286-46-2 | Details |
| Glimepiride methyl ester | C18H23N3O6S | 119018-30-3 | Details |
| Oseltamivir degradation impurity 1 | Details |
| Oseltamivir degradation impurity 2 | Details |
| 1,1'-(4-(ethylamino)-6-hydroxy-1,3-phenylene)bis(ethan-1-one) | C12H15NO3 | 79324-49-5 | Details |
| Iodonitrotetrazolium chloride | C19H13ClIN5O2 | 146-68-9 | Details |
| 1,1'-(4-amino-6-hydroxy-1,3-phenylene)bis(ethan-1-one) | C10H11NO3 | 79324-45-1 | Details |
| 1,1'-(4-(allyloxy)-6-(ethylamino)-1,3-phenylene)bis(ethan-1-one) | C15H19NO3 | 79324-50-8 | Details |
| 4-chloro-5-nitro-2-(propylthio)pyrimidine | C7H8ClN3O2S | 2518331-26-3 | Details |
| 4-methoxy-5-nitro-2-(propylthio)pyrimidine | C8H11N3O3S | 2514951-26-7 | Details |
| 1-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione | C7H10N2O3 | 69998-14-7 | Details |
| Mavacamten MYK461 (S)-3-isopropyl-6-((1-phenylethyl)amino)pyrimidine-2,4(1H,3H)-dione | C15H19N3O2 | 1642288-47-8 | Details |
| N-(2,4-diacetyl-5-hydroxyphenyl)acetamide | C12H13NO4 | 79324-44-0 | Details |
| 5-amino-2-(propylthio)pyrimidin-4-ol | Details |
| 1,1'-(4-(ethylamino)-6-hydroxy-5-propyl-1,3-phenylene)bis(ethan-1-one) | C15H21NO3 | 79324-51-9 | Details |
| 6-chloro-3-isopropylpyrimidine-2,4(1H,3H)-dione | C7H9ClN2O2 | 887581-47-7 | Details |
| LCL161 | C26H33FN4O3S | 1005342-46-0 | Details |
| GDC-0276 | C24H31FN2O4S | 1494581-70-2 | Details |
| GSK-2110183C impurity d-M14 | Details |
| GSK-2110183C | C18H17Cl2FN4OS | 1047644-62-1 | Details |
| Mefatinib | C21H19ClF3N5O2 | 1417695-74-9 | Details |
| GDC-0310 intermediate 1 | C22H31ClFNO5 | 1788072-29-6 | Details |
| GDC-0310 intermediate 3 | Details |
| MK-1755 intermediate 4 | C17H19N5O2S | 955369-56-9 | Details |
| GDC-0310 | C25H29Cl2FN2O4S | 1788063-52-4 | Details |
| GDC-0310 intermediate 2 | C25H36FNO5 | 1788072-30-9 | Details |
| d-Mefatinib | Details |
| Carbamic acid, N-?[(1S)?-?1-?cyclohexyl-?2-?[(2S)?-?2-?[4-?(4-?fluorobenzoyl)?-?2-?thiazolyl]?-?1-?pyrrolidinyl]?-?2-?oxoethyl]?-?, 1,?1-?dimethylethyl ester | C27H34FN3O4S | 1005342-80-2 | Details |
| MK-1755 intermediate 2 | C16H24N4O4S | 2007908-48-5 | Details |
| MK-1755 intermediate 3 | C9H10N4OS | 955368-90-8 | Details |
| GDC-0310 intermediate 4 | C25H28Cl2FNO3 | 2448100-15-8 | Details |
| JH-VIII-157-02 | C28H27N5O2 | 1639422-97-1 | Details |
| GSK-2110183C impurity M14 | Details |
| (S)-(4-Fluorophenyl)(2-(pyrrolidin-2-yl)thiazol-4-yl)methanone hydrochloride | C14H14ClFN2OS | 1263876-35-2 | Details |
| Testosterone Tridecanoate | C32H52O3 | 488836-58-4 | Details |
| GSK-2110183C intermediate | C9H6Cl2N2O2S | 1047630-61-4 | Details |
| MK-1755 intermediate 1 | C8H16N2O2 | 21075-86-5 | Details |
| L-Threonine, N-[4-[2-[4-(4-morpholinylmethyl)phenyl]ethynyl]benzoyl]-, methyl ester | C25H28N2O5 | 728878-12-4 | Details |
| Oxobutanedioic acid | C4H4O5 | 328-42-7 | Details |
| L-Threonine, N-(4-ethynylbenzoyl)-, methyl ester | C14H15NO4 | 728878-24-8 | Details |
| 4-aMino-3-Methoxy-N-(1-Methylpiperidin-4-yl)benzaMide | C14H21N3O2 | 876126-60-2 | Details |
| CHIR090 | C24H27N3O5 | 728865-23-4 | Details |
| BI-2536 parent nucleus | C14H19ClN4O | 755039-55-5 | Details |
| MK-1755 | C27H32N8O2 | 955365-80-7 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 | ||||